Berberine modulates Keratin 17 to inhibit cervical cancer cell viability and metastasis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103(5):368–383.
   PubMedGoogle Scholar
• Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res. 2008;22(8):999–1012.
   PubMed Web of Science ®Google Scholar
• Wang K, Feng X, Chai L, et al. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. 2017;49(2):139–157.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang W, Tong Y. Berberine inhibits proliferative ability of breast cancer cells by reducing metadherin. Med Sci Monit. 2019;25:9058–9066.
   PubMed Web of Science ®Google Scholar
• Mercado G, Castillo V, Soto P, et al. Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease. Neurobiol Dis. 2018;112:136–148.
   PubMed Web of Science ®Google Scholar
• Chu S-C, Yu C-C, Hsu L-S, et al. Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells. Mol Pharmacol. 2014;86(6):609–623.
   PubMed Web of Science ®Google Scholar
• Liu C, Wang Z, Song Y, et al. Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo. Biomed Res Int. 2015;2015:313808.
   PubMed Web of Science ®Google Scholar
• Kou Y, Li L, Li H, et al. Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells. Biochem Biophys Res Commun. 2016;479(2):290–296.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu L, Cao L, et al. Keratin 17 promotes lung adenocarcinoma progression by enhancing cell proliferation and invasion. Med Sci Monit. 2018;24:4782–4790.
   PubMed Web of Science ®Google Scholar
• Hobbs RP, Batazzi AS, Han MC, et al. Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo. Oncogene. 2016;35(43):5653–5662.
   PubMed Web of Science ®Google Scholar
• Wang Y-F, Lang H-Y, Yuan J, et al. Overexpression of keratin 17 is associated with poor prognosis in epithelial ovarian cancer. Tumour Biol. 2013;34(3):1685–1689.
   PubMedGoogle Scholar
• Depianto D, Kerns ML, Dlugosz AA, et al. Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet. 2010;42(10):910–914.
   PubMed Web of Science ®Google Scholar
• Escobar-Hoyos LF, Yang J, Zhu J, et al. Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker. Mod Pathol. 2014;27(4):621–630.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Zuo Z, Huang P, Jiang Y, et al. Acupuncture attenuates renal interstitial fibrosis via the TGF‑β/Smad pathway. Mol Med Rep. 2019;20(3):2267–2275.
   PubMed Web of Science ®Google Scholar
• Conrad LB, Ramirez PT, Burke W, et al. Role of minimally invasive surgery in gynecologic oncology: an updated survey of members of the society of gynecologic oncology. Int J Gynecol Cancer. 2015;25(6):1121–1127.
   PubMed Web of Science ®Google Scholar
• Fader AN. Surgery in cervical cancer. N Engl J Med. 2018;379(20):1955–1957.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen J, Chen F, et al. Tauroursodeoxycholic acid alleviates secondary injury in the spinal cord via up-regulation of CIBZ gene. Cell Stress Chaperones. 2018;23(4):551–560.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71(10):1397–1421.
   PubMed Web of Science ®Google Scholar
• Gu L, Li N, Gong J, et al. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infect Dis. 2011;203(11):1602–1612.
   PubMed Web of Science ®Google Scholar
• Shan Y-Q, Ren G, Wang Y-X, et al. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux. Metab Clin Exp. 2013;62(3):446–456.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang X, Tan H-Y, et al. Berberine suppresses cyclin D1 expression through proteasomal degradation in human hepatoma cells. Int J Mol Sci. 2016;17(11):1899.
   Web of Science ®Google Scholar
• Pan Y, Zhang F, Zhao Y, et al. Berberine enhances chemosensitivity and induces apoptosis through dose-orchestrated AMPK signaling in breast cancer. J Cancer. 2017;8(9):1679–1689.
   PubMed Web of Science ®Google Scholar
• Hu Q, Li L, Zou X, et al. Berberine attenuated proliferation, invasion and migration by targeting the AMPK/HNF4α/WNT5A pathway in gastric carcinoma. Front Pharmacol. 2018;9:1150.
   PubMed Web of Science ®Google Scholar
• Kim S, Lee J, You D, et al. Berberine suppresses cell motility through downregulation of TGF-β1 in triple negative breast cancer cells. Cell Physiol Biochem. 2018;45(2):795–807.
   PubMedGoogle Scholar
• Naveen CR, Gaikwad S, Agrawal-Rajput R. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial–mesenchymal transition in neuroblastoma cells. Phytomedicine. 2016;23(7):736–744.
   PubMed Web of Science ®Google Scholar
• Mahata S, Bharti AC, Shukla S, et al. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer. 2011;10:39.
   PubMed Web of Science ®Google Scholar
• Zhang G, Wang C, Sun M, et al. Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells. Oncotarget. 2016;7(20):28935–28946.
   PubMedGoogle Scholar
• Lee HJ, Lee E-K, Seo YE, et al. Roles of Bcl-2 and caspase-9 and -3 in CD30-induced human eosinophil apoptosis. J Microbiol Immunol Infect. 2017;50(2):145–152.
   PubMedGoogle Scholar
• Hassan M, Watari H, AbuAlmaaty A, et al. Apoptosis and molecular targeting therapy in cancer. Biomed Res Int. 2014;2014:150845.
   PubMed Web of Science ®Google Scholar
• Sari LM, Subita GP, Auerkari EI. Areca nut extract demonstrated apoptosis-inducing mechanism by increased caspase-3 activities on oral squamous cell carcinoma. F1000Res. 2018;7:723.
   PubMedGoogle Scholar
• Wang Y, Liu Y, Du X, et al. The anti-cancer mechanisms of berberine: a review. Cancer Manag Res. 2020;12:695–702.
   PubMed Web of Science ®Google Scholar
• Liao C-L, Chu YL, Lin H-Y, et al. Bisdemethoxycurcumin suppresses migration and invasion of human cervical cancer hela cells via inhibition of NF-ĸB, MMP-2 and -9 pathways. Anticancer Res. 2018;38(7):3989–3997.
   PubMed Web of Science ®Google Scholar
• Terry S, Chouaib S. EMT in immuno-resistance. Oncoscience. 2015;2(10):841–842.
   PubMedGoogle Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–196.
   PubMed Web of Science ®Google Scholar
• Lotfi A, Mohammadi G, Tavassoli A, et al. Serum levels of MMP9 and MMP2 in patients with oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2015;16(4):1327–1330.
   PubMedGoogle Scholar
• Sun L, Zhang Y, Lou J. ARHGAP9 siRNA inhibits gastric cancer cell proliferation and EMT via inactivating Akt, p38 signaling and inhibiting MMP2 and MMP9. Int J Clin Exp Pathol. 2017;10(12):11979–11985.
   PubMed Web of Science ®Google Scholar
• Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14(10):611–629.
   PubMed Web of Science ®Google Scholar
• Li J, Chen Q, Deng Z, et al. KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells. Life Sci. 2019;224:255–262.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang MQ, Lei L, et al. Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis. Cancer Manag Res. 2019;11:7485–7497.
   PubMed Web of Science ®Google Scholar